Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-9054 in ocular hypertension or open-angle glaucoma
NCT02083289Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- May 2014
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 2 trial of sepetaprost in ocular hypertension, Open-angle glaucoma (OAG), sponsored by Ono Pharmaceutical. Started May 2014; status: completed.
02
Drugs
sepetaprost
03
Conditions
ocular hypertensionOpen-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT02083289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02083289.